We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
+$31.2M
Cap. Flow
+$169M
Cap. Flow %
8.75%
Top 10 Hldgs %
45.68%
Holding
151
New
31
Increased
40
Reduced
42
Closed
31

Top Buys

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$104M
2
EHC icon
Encompass Health
EHC
+$86.2M
3
CTRE icon
CareTrust REIT
CTRE
+$42.1M
4
UNH icon
UnitedHealth
UNH
+$19M
5
INSM icon
Insmed
INSM
+$18.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.9M
2
NTRA icon
Natera
NTRA
+$44.5M
3
DOC icon
Healthpeak Properties
DOC
+$32.5M
4
AVTR icon
Avantor
AVTR
+$23.3M
5
QGEN icon
Qiagen
QGEN
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.53%
2 Real Estate 5.59%
3 Miscellaneous 4.84%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$20.9B
$156M 8.09%
287,668
+23,397
+9% +$13.2M
ABVX
2
Abivax
ABVX
$10B
$122M 6.32%
913,880
-20,543
-2% -$2.32M
EHC icon
3
Encompass Health
EHC
$12B
$104M 5.38%
1,026,919
+832,815
+429% +$86.2M
ENSG icon
4
The Ensign Group
ENSG
$9.95B
$96.5M 5.01%
602,079
+587,318
+3,979% +$104M
VERA icon
5
Vera Therapeutics
VERA
$2.59B
$94.9M 4.93%
2,212,770
+39,484
+2% +$1.47M
QQQ icon
6
PUT
Invesco QQQ Trust
QQQ
$490B
$72.6M 3.77%
98,600
-140,100
-59% -$96.4M
CLDX icon
7
Celldex Therapeutics
CLDX
$3.12B
$66.5M 3.45%
1,785,941
-2,075
-0.1% -$67K
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.84B
$61.2M 3.17%
2,798,210
-87,412
-3% -$1.82M
BKD icon
9
Brookdale Senior Living
BKD
$2.81B
$54.6M 2.84%
3,396,470
-172,085
-5% -$2.34M
IONS icon
10
Ionis Pharmaceuticals
IONS
$9.65B
$52.7M 2.73%
664,684
+32,584
+5% +$2.45M
NTRA icon
11
Natera
NTRA
$47.3B
$47.7M 2.48%
175,807
-208,906
-54% -$44.5M
TVTX icon
12
Travere Therapeutics
TVTX
$6.15B
$45.4M 2.35%
798,973
+256,363
+47% +$11.4M
CTRE icon
13
CareTrust REIT
CTRE
$9.22B
$43.3M 2.24%
+1,072,015
New +$42.1M
HCA icon
14
HCA Healthcare
HCA
$87.7B
$38.3M 1.99%
98,252
+19,023
+24% +$8.04M
PCVX icon
15
Vaxcyte
PCVX
$9.1B
$36.6M 1.9%
629,952
-294,241
-32% -$16M
LQDA icon
16
Liquidia Corp
LQDA
$6.15B
$34.2M 1.77%
428,652
-248,740
-37% -$13.3M
CYH icon
17
Community Health Systems
CYH
$408M
$26.3M 1.36%
7,864,575
-812,706
-9% -$2.39M
GSK icon
18
GSK
GSK
$100B
$25.3M 1.31%
481,833
-1,303,342
-73% -$68.9M
CHE icon
19
Chemed
CHE
$6.79B
$24.5M 1.27%
52,523
+21,466
+69% +$9.03M
LLY icon
20
Eli Lilly
LLY
$1.02T
$24.1M 1.25%
20,116
+1,116
+6% +$1.14M
GERN icon
21
Geron
GERN
$1.01B
$24M 1.24%
18,717,422
-117,461
-0.6% -$165K
VKTX icon
22
Viking Therapeutics
VKTX
$4.07B
$23.5M 1.22%
602,922
+363,812
+152% +$11.8M
OHI icon
23
Omega Healthcare
OHI
$14.1B
$23.1M 1.2%
483,547
-102,133
-17% -$4.73M
PODD icon
24
Insulet
PODD
$10.2B
$22.7M 1.18%
148,816
+5,270
+4% +$878K
THC icon
25
Tenet Healthcare
THC
$21.3B
$21.4M 1.11%
114,199
+84,687
+287% +$15.6M
1
2 3 4 5

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Eversept Partners held 151 positions worth $1.93B, up 1.6% from $1.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Eversept Partners deployed $169M of net new capital in Q2 2026, opening 31 new positions and adding to 40 existing holdings. Its largest new stake was CareTrust REIT: 1,072,015 shares worth $43.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 74% a quarter earlier, followed by Real Estate and Miscellaneous.

On the sell side, the largest reduction was GSK, an estimated $68.9M trimmed.

  • Eversept Partners's largest Q2 2026 buy was CareTrust REIT: 1,072,015 shares worth $43.3M.
  • Eversept Partners added most to The Ensign Group in Q2 2026, an estimated $104M increase.
  • Eversept Partners's biggest Q2 2026 reduction was GSK, cutting an estimated $68.9M.
  • Eversept Partners fully exited Healthpeak Properties in Q2 2026, selling an estimated $32.5M.
  • Eversept Partners's ten largest holdings make up 46% of its $1.93B portfolio in Q2 2026.
  • Eversept Partners opened 31 new positions and closed 31 in Q2 2026.
  • Eversept Partners's portfolio value rose 1.6% quarter-over-quarter to $1.93B.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.